ID: | F10 | |
---|---|---|
Name: | Disopyramide | |
Description: | ||
Labels: | ||
CAS: | 3737-09-5 | |
InChi Code: | InChI=1/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25) |
Class_pH3: Class of membrane permeability at pH 3 i
Value | Source or prediction |
---|---|
L |
M1: Model at pH 3 with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
L |
M7: Model at pH 3 with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_pH5: Class of membrane permeability at pH 5 i
Value | Source or prediction |
---|---|
L |
M2: Model at pH 5 with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
H |
M8: Model at pH 5 with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_pH7.4: Class of membrane permeability at pH 7.4 i
Value | Source or prediction |
---|---|
L |
M3: Model at pH 7.4 with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
H |
M9: Model at pH 7.4 with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_pH9: Class of membrane permeability at pH 9 i
Value | Source or prediction |
---|---|
H |
M4: Model at pH 9 with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
H |
M10: Model at pH 9 with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_highest: Class of highest membrane permeability for pH range 3 to 9 i
Value | Source or prediction |
---|---|
H |
M5: Model for highest membrane permeability with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
H |
M11: Model for highest membrane permeability with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_logPo: Class of intrinsic membrane permeability i
Value | Source or prediction |
---|---|
H |
M6: Model for intrinsic membrane permeability (logPo) with hydrophobicity descriptor (FDA reference drugs for BCS permeability class) |
H |
M12: Model for intrinsic membrane permeability (logPo) with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Class_FDA: BCS permeability class for FDA reference drugs i
Value | Source or prediction |
---|---|
H |
experimental value |
H |
Fig5_1: Decision tree based on models with hydrophobicity descriptors (FDA reference drugs for BCS permeability class) |
H |
Fig5_2: Decision tree based on the models with theoretical molecular descriptors (FDA reference drugs for BCS permeability class) |
Link | Resource description |
---|---|
DTXSID1045536 | US EPA CompTox Dashboard |